http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1262147-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d398f02a2928428293951aee6c95c176 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 1969-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1972-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1262147-A |
| titleOfInvention | Antimicrobial factors |
| abstract | 1,262,147. Antimicrobial factors. STANLEY DRUG PRODUCTS Inc. 4 March, 1969 [4 March, 1968], No. 11397/69. Heading ASB. Antimicrobial factor Z, a neutral fraction having antimicrobial properties a molecular weight below 2000, is derived from mammalian brain and spleen alcohol extracts by gel filtration. The factor may result from fractionation by gel filtration of an effluent derived by elution from charcoal by acidified water of the alcohol extract, factor Z being the aqueous elutant from the gel filtration resin having a pH of 4 to 5 in the elution pattern determined by a pH curve. The effluent may be the eluate resulting from the elution of the charcoal or the re-dissolved residue precipitated from the charcoal eluate at a neutral pH. The factor may be a slightly water soluble, acidified water soluble, waxy material having a molecular weight of 750 to 850, an elemental analysis of nitrogen, 1.68%; carbon, 68.47%; hydrogen, 11.47%; and oxygen, 18.38%, and comprises a mixture of cerebrosides predominately phrenosin. Pharmaceutical compositions for reducing the incidence of deleterious effects of infections due to cocci and bacilli comprise the antimicrobial factor Z and a physiologically acceptable, non-toxic, inert carrier. The compositions may be administered orally or parenterally in the form of injectable liquids, tablets or capsules. |
| priorityDate | 1968-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.